$1.70
-0.06 (-3.41%)
Allos Therapeutics, Inc. (NASDAQ:ALTH)
CAPS Rating:
A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.
A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.